News Home

Is Predictive Oncology Inc (POAI) Stock About to Get Hot Monday?

Monday, January 30, 2023 01:20 PM | InvestorsObserver Analysts

Mentioned in this article

Is Predictive Oncology Inc (POAI) Stock About to Get Hot Monday?

Predictive Oncology Inc (POAI) stock has gained 11.63% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bullish
Predictive Oncology Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on POAI!

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With POAI Stock Today?

Predictive Oncology Inc (POAI) stock is higher by 5.43% while the S&P 500 has fallen -0.81% as of 1:18 PM on Monday, Jan 30. POAI has risen $0.02 from the previous closing price of $0.46 on volume of 290,855 shares. Over the past year the S&P 500 has fallen -10.58% while POAI has fallen -45.45%. POAI lost -$0.37 per share in the over the last 12 months.

More About Predictive Oncology Inc

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Helomics, zPREDICTA, Soluble and Skyline. It derives prime revenue from the Skyline segment which consists of the STREAMWAY System product sales, and TumorGenesis subsidiary (Research and Development) is included within corporate. The STREAMWAY System virtually eliminates staff exposure to blood, irrigation fluid, and other potentially infectious fluids found in the healthcare environment. Its Helomics division is focused on improving the effectiveness of cancer therapy using proprietary, multi-omic tumor profiling platform, a one-of-a-kind database of historical tumor data, and the power of AI to build predictive models of tumor drug response. Click Here to get the full Stock Report for Predictive Oncology Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App